First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

Ingrid Holst Olsen; Seppo W Langer; Ida Jepsen; Maria Assens; Birgitte Federspiel; Jane Preuss Hasselby; Carsten Palnaes Hansen; Andreas Kjaer; Ulrich Knigge

doi:10.3109/0284186X.2011.582881

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

Ingrid Holst Olsen, Seppo W Langer, Ida Jepsen, Maria Assens, Birgitte Federspiel, Jane Preuss Hasselby, Carsten Palnaes Hansen, Andreas Kjaer, Ulrich Knigge

16 Citations (Scopus)

Abstract

Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.

Original language	English
Journal	Acta Oncologica
Volume	51
Issue number	1
Pages (from-to)	97-100
Number of pages	4
ISSN	0284-186X
DOIs	https://doi.org/10.3109/0284186X.2011.582881
Publication status	Published - 2012

Access to Document

10.3109/0284186X.2011.582881

Cite this

Olsen, I. H., Langer, S. W., Jepsen, I., Assens, M., Federspiel, B., Hasselby, J. P., Hansen, C. P., Kjaer, A., & Knigge, U. (2012). First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience. Acta Oncologica, 51(1), 97-100. https://doi.org/10.3109/0284186X.2011.582881

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience. / Olsen, Ingrid Holst; Langer, Seppo W; Jepsen, Ida et al.
In: Acta Oncologica, Vol. 51, No. 1, 2012, p. 97-100.

Research output: Contribution to journal › Journal article › Research › peer-review

Olsen, IH, Langer, SW, Jepsen, I, Assens, M, Federspiel, B, Hasselby, JP , Hansen, CP , Kjaer, A & Knigge, U 2012, 'First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience', Acta Oncologica, vol. 51, no. 1, pp. 97-100. https://doi.org/10.3109/0284186X.2011.582881

@article{f79263d5fa0644e5907691a13a87396c,

title = "First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience",

abstract = "Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.",

author = "Olsen, \{Ingrid Holst\} and Langer, \{Seppo W\} and Ida Jepsen and Maria Assens and Birgitte Federspiel and Hasselby, \{Jane Preuss\} and Hansen, \{Carsten Palnaes\} and Andreas Kjaer and Ulrich Knigge",

year = "2012",

doi = "10.3109/0284186X.2011.582881",

language = "English",

volume = "51",

pages = "97--100",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "1",

}

TY - JOUR

T1 - First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

AU - Olsen, Ingrid Holst

AU - Langer, Seppo W

AU - Jepsen, Ida

AU - Assens, Maria

AU - Federspiel, Birgitte

AU - Hasselby, Jane Preuss

AU - Hansen, Carsten Palnaes

AU - Kjaer, Andreas

AU - Knigge, Ulrich

PY - 2012

Y1 - 2012

N2 - Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.

AB - Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.

UR - https://www.scopus.com/pages/publications/83455221060

U2 - 10.3109/0284186X.2011.582881

DO - 10.3109/0284186X.2011.582881

M3 - Journal article

C2 - 21615243

SN - 0284-186X

VL - 51

SP - 97

EP - 100

JO - Acta Oncologica

JF - Acta Oncologica

IS - 1

ER -

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

Abstract

Access to Document

Other files and links

Fingerprint

Cite this